Literature DB >> 15985739

Diagnosis and management of acyanotic heart disease: part I -- obstructive lesions.

P Syamasundar Rao1.   

Abstract

In this review, the clinical features and management of most commonly encountered acyanotic obstructive cardiac lesions are discussed. Mild lesions, especially in children are usually asymptomatic while neonates and infants may present with symptoms. Ejection systolic murmurs in patients with pulmonic and aortic stenosis and decreased femoral pulses and blood pressure difference (>20 mmHg) between arms and leg in patients with aortic coarctation are usually seen. Clinical diagnosis is not difficult and the diagnosis can be confirmed and quantitated by non-invasive echocardiographic studies. Whereas surgical intervention was used in the past, balloon dilatation appears to be effective in the treatment of these lesions.

Entities:  

Mesh:

Year:  2005        PMID: 15985739

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  5 in total

Review 1.  Consensus on timing of intervention for common congenital heart diseases: part I - acyanotic heart defects.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2012-06-30       Impact factor: 1.967

Review 2.  Diagnosis and management of cyanotic congenital heart disease: part I.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

Review 3.  Clinical Diagnostic Approach to Congenital Acyanotic Congenital Heart Disease in Infants and Children.

Authors:  Bhava Rj Kannan
Journal:  Indian J Pediatr       Date:  2020-04-01       Impact factor: 1.967

4.  Management of Congenital Heart Disease: State of the Art; Part I-ACYANOTIC Heart Defects.

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2019-03-08

Review 5.  The Author's Contributions to Echocardiography Literature (Part II-1991-2020).

Authors:  P Syamasundar Rao
Journal:  Children (Basel)       Date:  2020-04-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.